Conjugates controlled-release systems

Goldstein, D., Nassar, T., Lambert, G., Kadouche, J., and Benita, S. (2005), The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates, /. Controlled Release, 108,418-432. 

Drug Delivery. Philadelphia Taylor Francis. ISSN 1071-7544. Covers basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems and modes of entry, such as controlled release systems microcapsules, liposomes, vesicles, and macromolecular conjugates antibody targeting and protein/peptide delivery. Peer-reviewed. 

Gao, H., Wang, Y. N. Fan, Y. G., and Ma, J. B. (2006), Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(P-cyclodextrin)s and their nanoparticles as protein delivery systems, / Controlled Release, 112,301-311. 

Tayab, R A., Hydrophobic chitosan in controlled release delivery systems, M.S. Thesis, Department of Bioengineering, Clemson University, Clemson, SC, 1995. Shalaby S. W. and Ignatious, R S., Ionic Molecular Conjugates of Biodegradable Rully n-Acylated Derivatives of Poly(2-amino-2-deoxy-d-glucose) and Bioactive Polypeptides, U.S. Patent (to Biomeasure, Inc.) 5,665,702, 1997. 

J. H. Jeong, S. W. Kim and T. G. Park, A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. /. Control. Release, 93,183-191 (2003). 

The use of P(3HB) in drug delivery has been extensively studied over the past three decades. Tablets, melt-pressed disks and microspheres have been fabricated for controlled drug release applications [328]. Assesments in-vitro and in-vivo of the activity of the conjugates showed that P(3HB) is indeed a promising material for prolonged drug release systems [329]. 

H. Yano, F. Hirayama, M. Kamada, H. Arima, and K. Uekama, Colon-specific delivery of prednisolone-appended a-cyclodextrin conjugate alleviation of systemic side effect after oral administration,/. Control Release, 79 (1-3), 103-112, 2002. 

---